Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...

Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities From research goal to lab-ready sequences in hours: Latent-Y compresses weeks of ...

NVIDIA Corp. NVDA expanded its presence in life sciences AI through separate initiatives with Certara Inc. CERT and Silo ...

Close-up on the pipetting arm of a robot; some hydraulics and the top of a 96-well plate are also visible. A pipetting robot handles liquid in a laboratory in 2023. Researchers developing autonomous ...

Uncovering nature’s secrets is no easy task. The daily life of a scientist is often grueling, frustrating, and—perhaps surprisingly—boring as they repeat experiments over and over. Here’s where AI ...

AI is no longer just a support tool in drug development. This paper shows how it could help build faster, smarter, and more personalized cancer therapies, while also exposing the scientific and ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global AI Voice Agents in Healthcare Market size & share revenue was valued at ...